Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
A.C.T. Holdings
First derivation of human embryonic stem cells without exposure to cell feeders
April 10th, 2005
A.C.T. Holdings (ACTH) and Advanced Cell Technology, Inc., (ACT) reported the first derivation of human embryonic stem cells in completely feeder-layer-free and serum-free conditions. The research, which appears online (ahead of print) in the journal The Lancet, by ACT and its collaborators, describes a system for producing embryonic stem cells which markedly reduces the risk of contamination with pathogens that could be transmitted to patients and the population-at-large. To date, all human embryonic stem cell lines have been isolated in contact with either mouse or human cells that may have contaminated the stem cells with viruses or other...
Source: Aging & Elder Health Week (2005-04-10)
|
